Patents for C12R 1 - Micro-organisms (92,025)
09/2001
09/25/2001US6294175 Compounds
09/25/2001US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6
09/25/2001CA2216794C Use of streptomyces bacteria to control plant pathogens and degrade turf thatch
09/25/2001CA2137142C Method for increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
09/25/2001CA2110058C Hepatitis c virus (hcv) polypeptides
09/25/2001CA2091005C Microbiological process for hydroxylation of nitrogen-heterocyclic-carboxylic acids
09/25/2001CA1341297C Secretory expression in eukaryotes
09/23/2001CA2339307A1 Nucleotide sequences coding for the dapc gene and process for the production of l-lysine
09/20/2001WO2001068903A1 Modulating production of pneumococcal capsular polysaccharide
09/20/2001WO2001068891A1 Method of purifying shikimic acid
09/20/2001WO2001068885A1 Method of detecting protein-protein interaction
09/20/2001WO2001068864A1 Fungal transcriptional activator useful in methods for producing polypeptides
09/20/2001WO2001068833A2 Recombinant hhv8 dna
09/20/2001WO2001068827A1 A process for the production of human interferon alpha from genetically engineered yeast
09/20/2001WO2001068821A2 Novel subtilase enzymes having an improved wash performance on egg stains
09/20/2001WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine
09/20/2001WO2001068818A2 Hcv ns2/3 fragments and uses thereof
09/20/2001WO2001068809A1 Bacillus circulans b-65, cyclodextrin glucanotransferase obtained therefrom and use to produce cyclodextrin
09/20/2001WO2001067854A1 Chimeric animal model susceptible to human hepatitis c virus infection
09/20/2001WO2001034092A8 A novel medium for the production of betacarotene and other carotenoids from dunaliella salina (arl 5) and a strain of dunaliella salina for production of carotenes using the novel media
09/20/2001WO2001014538A3 Plants with modified polyunsaturated fatty acids
09/20/2001WO2001011006A3 Detection of micro-organisms
09/20/2001WO2001009306A9 Mutant bacterial strains l-lysine production
09/20/2001WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
09/20/2001WO2000037490A3 Outer surface proteins, their genes, and their use
09/20/2001WO2000018899A3 Angiotensin converting enzyme homolog and its use
09/20/2001US20010023259 Nutrients, drugs
09/20/2001US20010023242 Polypeptide from snake venom
09/20/2001US20010023062 Screening receptors
09/20/2001US20010022969 Sepsis therapy
09/20/2001DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides
09/20/2001DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects
09/20/2001CA2403405A1 Hcv ns2/3 fragments and uses thereof
09/20/2001CA2402866A1 Novel subtilase enzymes having an improved wash performance on egg stains
09/20/2001CA2402562A1 A process for the production of human interferon alpha from genetically engineered yeast
09/20/2001CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine
09/20/2001CA2374155A1 A detection method of protein-protein interaction
09/19/2001EP1134284A1 Creatine amidinohydrolase and process for producing the same
09/19/2001EP1134283A1 Method for producing L-Phenylalanine
09/19/2001EP1133691A2 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device
09/19/2001EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
09/19/2001EP1133570A1 Organisms for the extracellular production of riboflavin
09/19/2001EP1133563A2 Methods and molecules relating to cd39-like polypeptides
09/19/2001EP1133561A2 Protein fragments for use in protein targeting
09/19/2001EP1133554A2 Polypeptides having choline oxidase activity and nucleic acids encoding same
09/19/2001EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species
09/19/2001EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection
09/19/2001EP0638077B1 Chiral cyclopentene derivatives and their preparation
09/19/2001EP0610371B1 Thermostable xylanase from a strain of rhodothermus marinus
09/19/2001EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment
09/19/2001EP0591369B1 Capsid forming and cystein modified chimaeric ms2-coat protein
09/19/2001CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them
09/19/2001CN1313893A FY7 polymerase
09/19/2001CN1313771A Method for detection of i(legionella) bacteria employing purified antigen-specific antibodies
09/19/2001CN1071379C Process for recovering polyhydroalkanoates using centrifugal fractionation
09/19/2001CN1071378C Production of L-threonine by fermentation
09/18/2001US6291649 Anti-bodies binding adhesin-derived antigens
09/18/2001US6291642 Mammalian cell cycle protein
09/18/2001US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject.
09/18/2001US6291430 Mage-3 peptides presented by HLA class II molecules
09/18/2001US6291426 Strain of bacillus for controlling plant diseases and corn rootworm
09/18/2001US6291246 DNA virus vectors and methods for their preparation
09/18/2001US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections
09/18/2001US6291218 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
09/18/2001US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof
09/18/2001US6291209 Genetically engineered aspergillus; for use in generation of heterolgous polypeptides
09/18/2001US6291206 BMP receptor proteins
09/18/2001US6291205 Generating preferentially bonded recombinant proteins; transform cell, express expression vector in cells and recover genetically engineered protein
09/18/2001US6291204 Culturing genetically engineered cell containing farnesyl pyrophosphate and isopentyl pyrophosphate to express zeaxanthin; dna sequences encode geranylgeranyl pyrophosphate synthase and other enzymes from flavobacterium
09/18/2001US6291176 Identification of a DNA region potentially useful for the detection of mycobacterium kansasii
09/18/2001US6291156 Plant pest control
09/18/2001US6290965 DNA encoding human papillomavirus type 6A
09/18/2001US6290962 Urease-based vaccine and treatment for helicobacter infection
09/18/2001US6290953 May be a conjugate which includes a targeting portion adapted to target the conjugate to a specific cell type or anatomical location.
09/18/2001CA2149236C Novel xylanase, process for producing the same, method for the treatment of pulp, and production of xylo-oligosaccharides
09/18/2001CA2079802C Walk-through mutagenesis
09/18/2001CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor
09/18/2001CA1341292C The manufacture and expression of consensus human leukocyte interferon
09/13/2001WO2001066794A1 Molecular methods for detecting guar gum additions to locust bean gum
09/13/2001WO2001066767A2 Direct production of desacetylcephalosporin c
09/13/2001WO2001066761A1 Inorganic pyrophosphatases from lepidopters
09/13/2001WO2001066719A1 Novel gene cloned in human neuroblastoma and novel gene fragments
09/13/2001WO2001066716A1 Polypeptide having phosphodiesterase activity
09/13/2001WO2001066712A2 Variants with altered properties
09/13/2001WO2001066703A1 Production of lutein in microorganisms
09/13/2001WO2001066698A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord
09/13/2001WO2001066697A2 Serum free cultivation of primate embryonic stem cells
09/13/2001WO2001066573A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
09/13/2001WO2001009305A3 Purine metabolism genes in plants
09/13/2001WO1995020047A3 Production of acariogenic sugar substitutes
09/13/2001US20010022004 for expression inhibition/knockout of collagen, tumor necrosis factor, tat genes/proteins, and immunoglobulins
09/13/2001US20010021768 Protein
09/13/2001US20010021529 Installing a culture chamber under an arbitrarily controlled environment mimicking the living body, supplying a culture medium to the cell or tissue, and culturing; prevents cell or tissue contamination; efficiency
09/13/2001US20010021523 PQQ (pyrroloquinoline quinone); stabilized with one of aspartic acid, glutamic acid, alpha -ketoglutaric acid, malic acid, alpha- ketogluconic acid, alpha-cyclodextrin and an albumin
09/13/2001US20010021522 Culturing a microorganism having an ability to produce arachidonic acid and having reduced or lost delta5 desaturase activity by adding dioxabicyclco(3,3,0)octane derivative as desaturase inhibitor to produce dihomo-gamma-linolenic acid
09/13/2001US20010021519 Method and catalyst system for stereoselectively inverting a chiral center of a chemical compound
09/13/2001US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene
09/13/2001US20010021386 Salmonella vaccine
09/13/2001DE10010938A1 Anorganische Pyrophosphatasen aus Lepidopteren Inorganic pyrophosphatase of Lepidoptera
09/13/2001CA2402223A1 Direct production of desacetylcephalosporin c